Haemonetics | HAE - 销售和管理费用



金融业
股票价格
USD
资产
USD 2.37B
现金及等价物
USD 223.38M
销售成本
USD 136.58M
流动资产
USD 810.83M
流动负债
USD 263.24M
债务
USD 1.22B
EBIT
USD 57.46M
EBITDA
USD 96.17M
员工
3.02K
EPS每股收益
USD 1.14
股本和储备
USD 837.1M
销售毛利
USD 202.8M
债务利息支出
USD 5.08M
利息收入
USD 6.96M
贷款资金
USD 1.17B
市值
USD 4.42B
净收入
USD 33.01M
营业费用
USD 145.35M
营业利润
USD 57.46M
普通股股本
USD 45.47M
PE价格收益
17.35
税前利润
USD 47.57M
销售收入
USD 339M
销售和管理费用
USD 118.94M
股票
USD 306.74M
贸易债权人
USD 56.34M
应收帐款人
USD 216.07M


销售和管理费用 更改 日
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Cerus USD 19.33M 1.55M 2024-12
Cooper Companies USD 676.2M 303.1M 2026-03
Fresenius EUR 760M 17M 2026-06
Fresenius Medical Care EUR 736.01M 12.99M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
Haemonetics USD 118.94M 1.99M 2026-06
ICU Medical USD 151.92M 2.64M 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
Medtronic 2.96B 9M 2025-12
Merit Medical Systems USD 129.23M 18.76M 2026-06
Neogen USD 99.8M 1.3M 2026-03
OraSure Technologies USD 13.21M 3.29M 2025-12
Plus Therapeutics USD 4.26M 779K 2026-03
Quidel USD 189.7M 9.6M 2026-06
ResMed USD 290.65M 10.86M 2026-06
STAAR Surgical USD 38.64M 299K 2026-03
Steris USD 369.7M 17.9M 2026-06
Stryker USD 2.12B 32M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Terumo JPY 109.7B 5.11B 2026-06
Thermo Fisher Scientific USD 1.91B 111M 2026-06
US Physical Therapy USD 19M 731K 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06